Other OTC Pharmaceuticals (Pharmacies) - Southern Europe

  • Southern Europe
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$2.69bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 0.74%, resulting in a market volume of US$2.77bn by 2028.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$11.37 are generated in 2024.

Key regions: United Kingdom, Canada, France, Europe, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Southern Europe is experiencing significant growth and development. This can be attributed to several factors including customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Southern Europe are driving the growth of the Other OTC Pharmaceuticals (Pharmacies) market. Consumers in this region are increasingly seeking self-care options and are turning to over-the-counter (OTC) medicines to address their healthcare needs. This preference for self-care is driven by factors such as convenience, affordability, and accessibility. Additionally, consumers in Southern Europe are becoming more health-conscious and are proactively seeking preventive healthcare solutions, which further fuels the demand for OTC pharmaceuticals. Trends in the market also contribute to the development of the Other OTC Pharmaceuticals (Pharmacies) market in Southern Europe. One key trend is the increasing availability and variety of OTC medicines in pharmacies. Pharmacies are expanding their product offerings to cater to the growing demand for OTC pharmaceuticals. This includes a wider range of products, including vitamins, supplements, and herbal remedies. Pharmacies are also investing in technology and digital platforms to enhance the customer experience and provide personalized recommendations. Local special circumstances in Southern Europe further impact the growth of the Other OTC Pharmaceuticals (Pharmacies) market. One such circumstance is the aging population in many countries in the region. As the population ages, there is a greater need for healthcare products and services, including OTC pharmaceuticals. This demographic shift creates a significant market opportunity for pharmacies in Southern Europe to cater to the healthcare needs of the elderly population. Underlying macroeconomic factors also play a role in the development of the Other OTC Pharmaceuticals (Pharmacies) market in Southern Europe. The region has been experiencing economic growth, which has led to increased disposable income and improved healthcare infrastructure. This enables consumers to afford and access OTC pharmaceuticals more easily. Additionally, favorable government regulations and policies support the growth of the OTC pharmaceutical market in Southern Europe. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Southern Europe is experiencing growth and development due to customer preferences for self-care, trends in the market, local special circumstances such as an aging population, and underlying macroeconomic factors including economic growth and favorable regulations. This presents opportunities for pharmacies in the region to expand their product offerings and enhance customer experience to meet the growing demand for OTC pharmaceuticals.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)